Detalles de la búsqueda
1.
Argyreia nervosa-driven biosynthesis of Cu-Ag bimetallic nanoparticles from plant leaves extract unveils enhanced antibacterial properties.
Bioprocess Biosyst Eng
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698218
2.
Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition.
Am J Physiol Endocrinol Metab
; 314(5): E418-E432, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29066462
3.
Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.
Am J Physiol Gastrointest Liver Physiol
; 314(3): G360-G377, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29122749
4.
Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
Infect Immun
; 85(1)2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27795363
5.
Goblet Cell Derived RELM-ß Recruits CD4+ T Cells during Infectious Colitis to Promote Protective Intestinal Epithelial Cell Proliferation.
PLoS Pathog
; 11(8): e1005108, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26285214
6.
SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens.
PLoS Pathog
; 9(8): e1003539, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23950714
7.
Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses.
Infect Immun
; 82(9): 3753-63, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24958710
8.
Dietary oils modify the host immune response and colonic tissue damage following Citrobacter rodentium infection in mice.
Am J Physiol Gastrointest Liver Physiol
; 304(10): G917-28, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23518681
9.
Modulation of early ß-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunity.
Infect Immun
; 79(5): 2043-50, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21383053
10.
Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.
Front Immunol
; 9: 2211, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30319652
11.
Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.
PLoS One
; 10(5): e0125225, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25932952
12.
DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat.
J Vis Exp
; (84): e51297, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24637969
13.
The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis.
J Vis Exp
; (72): e50222, 2013 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23462619
14.
Partial depletion of CD4(+)CD25(+)Foxp3(+) T regulatory cells significantly increases morbidity during acute phase Toxoplasma gondii infection in resistant BALB/c mice.
Microbes Infect
; 13(4): 394-404, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21262371
Resultados
1 -
14
de 14
1
Próxima >
>>